These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11522483)

  • 1. Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol.
    Kotiyan PN; Vavia PR
    Eur J Pharm Biopharm; 2001 Sep; 52(2):173-80. PubMed ID: 11522483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
    Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems.
    Cilurzo F; Selmin F; Gennari CG; Montanari L; Minghetti P
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1033-45. PubMed ID: 24766369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation optimization and stability study of transdermal therapeutic system of nicorandil.
    Tipre DN; Vavia PR
    Pharm Dev Technol; 2002; 7(3):325-32. PubMed ID: 12229264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization of beta-estradiol in an acrylic transdermal drug delivery system.
    Variankaval NE; Jacob KI; Dinh SM
    J Biomed Mater Res; 1999 Mar; 44(4):397-406. PubMed ID: 10397943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development and in vitro evaluation of estradiol transdermal film-forming spray].
    Yu ZW; Liang Y; Liang WQ
    Yao Xue Xue Bao; 2013 May; 48(5):746-51. PubMed ID: 23888700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the transdermal permeation behavior of Proterguride from drug in adhesive matrix patches through hairless mouse skin.
    Schurad B; Tack J; Lipp R
    Drug Dev Ind Pharm; 2005 Jul; 31(6):505-13. PubMed ID: 16109623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Different Mixing Methods on the Performance of Suspension-Based Transdermal Delivery Systems.
    Bhattaccharjee SA; Kale M; Le N; Banga AK
    AAPS PharmSciTech; 2021 May; 22(4):150. PubMed ID: 33973096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen.
    Cilurzo F; Minghetti P; Casiraghi A; Tosi L; Pagani S; Montanari L
    Eur J Pharm Biopharm; 2005 May; 60(1):61-6. PubMed ID: 15848057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.
    Mukherjee B; Mahapatra S; Gupta R; Patra B; Tiwari A; Arora P
    Eur J Pharm Biopharm; 2005 Apr; 59(3):475-83. PubMed ID: 15760728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix.
    Kim JH; Choi HK
    Int J Pharm; 2002 Apr; 236(1-2):81-5. PubMed ID: 11891072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
    Aqil M; Ali A; Sultana Y; Najmi AK
    Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
    Mohamed LA; Kamal N; Elfakhri KH; Willett D; Wokovich A; Strasinger C; Cruz CN; Raney SG; Ashraf M; Zidan AS
    Int J Pharm; 2020 Mar; 578():119132. PubMed ID: 32057892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
    Subedi RK; Ryoo JP; Moon C; Choi HK
    Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and evaluation of Eudragit
    Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB
    Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.
    Chien YW; Chien TY; Bagdon RE; Huang YC; Bierman RH
    Pharm Res; 1989 Dec; 6(12):1000-10. PubMed ID: 2516312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
    Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
    J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adhesive layer thickness and drug loading on estradiol crystallization in a transdermal drug delivery system.
    Imani M; Lahooti-Fard F; Taghizadeh SM; Takrousta M
    AAPS PharmSciTech; 2010 Sep; 11(3):1268-75. PubMed ID: 20706877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.